Phio Pharmaceuticals (PHIO) Change in Account Payables (2016 - 2021)
Historic Change in Account Payables for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to -$39000.0.
- Phio Pharmaceuticals' Change in Account Payables fell 17857.14% to -$39000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$445000.0, marking a year-over-year decrease of 44938.27%. This contributed to the annual value of -$404000.0 for FY2024, which is 23114.75% down from last year.
- According to the latest figures from Q4 2021, Phio Pharmaceuticals' Change in Account Payables is -$39000.0, which was down 17857.14% from -$26000.0 recorded in Q3 2021.
- Phio Pharmaceuticals' 5-year Change in Account Payables high stood at $261000.0 for Q3 2020, and its period low was -$447000.0 during Q1 2017.
- Moreover, its 5-year median value for Change in Account Payables was -$32500.0 (2017), whereas its average is -$41800.0.
- In the last 5 years, Phio Pharmaceuticals' Change in Account Payables skyrocketed by 161000.0% in 2019 and then tumbled by 146000.0% in 2020.
- Phio Pharmaceuticals' Change in Account Payables (Quarter) stood at -$191000.0 in 2017, then surged by 130.89% to $59000.0 in 2018, then plummeted by 179.66% to -$47000.0 in 2019, then soared by 70.21% to -$14000.0 in 2020, then crashed by 178.57% to -$39000.0 in 2021.
- Its Change in Account Payables was -$39000.0 in Q4 2021, compared to -$26000.0 in Q3 2021 and -$267000.0 in Q2 2021.